Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
01/2012
01/12/2012US20120010206 Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases
01/12/2012US20120010205 Novel quinoline esters useful for treating skin disorders
01/12/2012US20120010204 Phthalazinone Derivatives
01/12/2012US20120010203 Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments
01/12/2012US20120010202 Polymerizable benzoxazine compounds with interfacial active or surface active properties
01/12/2012US20120010201 Novel anellated pyridine compounds
01/12/2012US20120010200 Biaryl Heterocyclic Compounds And Methods Of Making And Using The Same
01/12/2012US20120010199 Novel pyrrolinone derivative and pharmaceutical composition comprising the same
01/12/2012US20120010191 Pyridone and aza-pyridone compounds and methods of use
01/12/2012US20120010190 1-hydroxyimino-3-phenyl-propanes
01/12/2012US20120010189 (3-(4-(aminomethyl)phenoxy or phenylthio)azetidin-1-yl)(5-phenyl-1,3,4-oxadiazol-2-yl)methanone compounds
01/12/2012US20120010188 Imidazopyridine Compounds
01/12/2012US20120010185 New pyridone derivates with mch antagonistic activity and medicaments comprising these compounds
01/12/2012US20120010184 Therapeutic Uses of Compounds Which Selectively Modulate The CB2 Receptor
01/12/2012US20120010181 Compounds for the treatment of inflammatory disorders
01/12/2012US20120010172 Novel urea and thiourea derivatives
01/12/2012US20120009151 Triazines And Related Compounds Having Antiviral Activity, Compositions And Methods Thereof
01/12/2012US20120009141 Functionalized pyrrolidines and use thereof as iap inhibitors
01/12/2012CA2805452A1 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators
01/12/2012CA2804329A1 Bisaryl (thio)morpholine derivatives as s1p modulators
01/12/2012CA2803717A1 (3-methylpyrrolidin-3-yl) methyl pyridinyl ether derivatives and their use as nk-3 receptor antagonists
01/12/2012CA2803248A1 Compounds and methods for the treatment or prevention of flavivirus infections
01/12/2012CA2802832A1 Therapeutic agents 976
01/11/2012EP2404920A1 Crystalline form of Rivaroxaban dihydrate
01/11/2012EP2404917A1 Tetrazoyl oxime derivative, salt thereof, and plant disease control agent
01/11/2012EP2404905A1 New compounds
01/11/2012EP2404902A1 Piperidine and pyrrolidine derivatives having npy y5 receptor antagonism
01/11/2012EP2404901A1 1,2-Disubstituted 4-benzylamino-pyrrolidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
01/11/2012EP2403850A1 Novel crystalline hydrate, amorphous and polymorphic forms of dihydro-benzoxazole-6-yl-acetamide derivative and processes for their preparation
01/11/2012EP2403849A1 Oxazole pyridine derivatives useful as s1p1 receptor agonists
01/11/2012EP2403848A1 Pharmaceutical hypocholesterolemic compositions
01/11/2012EP2403846A1 Inhibitors of bruton's tyrosine kinase
01/11/2012EP2403835A1 Novel phenyl imidazoles and phenyl triazoles as gamma-secretase modulators
01/11/2012EP2403833A1 8-substituted quinolines and related analogs as sirtuin modulators
01/11/2012EP2403832A1 N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
01/11/2012EP2403340A1 Compounds and compositions for cognition-enhancement, methods of making, and methods of treating
01/11/2012EP2403338A1 Imidazole derivatives useful as modulators of faah and as faah imaging agents
01/11/2012EP2152690B1 Pyridyl piperidine orexin receptor antagonists
01/11/2012EP1486549B1 Organic electroluminescent element
01/11/2012CN102317282A Hetero ring derivative
01/11/2012CN102317278A 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
01/11/2012CN102317275A Novel herbicides
01/11/2012CN102317270A Isoxazole-isoxazole and isoxazole-isothiazole derivatives
01/11/2012CN102317269A Novel amino azaheterocyclic carboxamides
01/11/2012CN102317268A 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors
01/11/2012CN102317266A 6-phenylpyrimidinones as PIM modulators
01/11/2012CN102311430A Novel crystalline state of iloperidone and preparation method thereof
01/11/2012CN102311403A 4,5-diaminocyclopentyl-2-enol derivative
01/11/2012CN102311400A Method for preparing 5(S)-aminomethyl-3-aryl-2-oxazolidinone
01/11/2012CN102311399A Triazole alcohol antifungal compounds with nitrogen-containing side chains, preparation method thereof and application thereof
01/11/2012CN102311387A 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
01/11/2012CN102311378A Fused pyrazole derivatives and uses thereof in methods of treatment of metabolic-related disorders
01/11/2012CN101735209B Method for synthesizing chiral dorzolamide hydrochloride
01/11/2012CN101346353B Sulfonamide derivatives and use thereof for the modulation of metalloproteinases
01/11/2012CN101228155B Substituted oxadiazole derivatives as positive allosteric modulators of metabotropic glutamate receptors
01/10/2012US8093399 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative
01/10/2012US8093389 e.g. 1-[(1-Ethyl-4-methoxy-1H-benzimidazol-6-yl)carbonyl]-6-(1H-tetrazol-5-yl)spiro[chroman-2,4'-piperidine]-4-one; acetyl CoA carboxylase inhibitors; antidiabetic, hypoglycemic agent; metabolic syndrome, fatty liver, hyperlipemia, obesity, diabetes, bulimia, malignant neoplasm or infectious diseases
01/10/2012US8093278 Substituted indoles
01/10/2012US8093244 Heteroaryl urea derivatives useful for inhibiting CHK1
01/10/2012US8093243 Hepatitis C virus inhibitors
01/10/2012US8093239 Imidazopyridine kinase inhibitors
01/05/2012WO2012003498A1 2 -quinolinyl- acetic acid derivatives as hiv antiviral compounds
01/05/2012WO2012003405A1 Sgc stimulators
01/05/2012WO2012003283A1 Heterocyclic compounds and their use as inhibitors of pi3k activity
01/05/2012WO2012003274A1 Heterocyclic compounds and their use as inhibitors of pi3k activity
01/05/2012WO2012002680A2 2-pyridyl substituted imidazoles as therapeutic alk5 and/or alk4 inhibitors
01/05/2012WO2012002577A1 Novel nicotinamide derivatives or salts thereof
01/05/2012WO2012002096A1 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides
01/05/2012WO2012001107A1 Piperidine derivatives and their use for the treatment of metabolic disorders
01/05/2012WO2012000519A1 Aryl- and heteroarylamid derivatives as pde10a enzyme inhibitor
01/05/2012WO2012000154A1 5-arylmethoxy phenyl pyrazole compounds and preparation methods thereof
01/05/2012WO2011099764A3 Novel pyrimidine derivative for inhibiting the growth of cancer cells
01/05/2012US20120004397 Violet laser excitable dyes and their method of use
01/05/2012US20120004230 Imidazole derivatives
01/05/2012US20120004229 Substituted diketopiperazines and their use as oxytocin antagonists
01/05/2012US20120004228 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors
01/05/2012US20120004227 Cyclohexane derivative having npy y5 receptor antagonism
01/05/2012US20120004225 Bumetanide, furosemide, piretanide, azosemide, and torsemide analogs, compositions and methods of use
01/05/2012US20120004224 Triheterocyclic Compounds and Compositions Thereof
01/05/2012US20120004218 Novel tetrahydro-quinoline derivatives
01/05/2012US20120004217 Therapeutic agents useful for treating pain
01/05/2012US20120004213 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE
01/05/2012US20120004208 Benzoyl-piperidine derivatives as dual modulators of the 5-ht2a and d3 receptors
01/05/2012US20120004207 Therapeutic uses of derivatives of piperidinyl-and piperidinyl-alkyl carbamates
01/05/2012US20120004198 Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
01/05/2012US20120004197 Prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient
01/05/2012US20120004196 Anti-Viral Compounds
01/05/2012US20120003229 Modulators of cytokine mediated signalling pathways and integrin alphavbeta3 receptor antagonists for combination therapy
01/05/2012US20120003215 Pyrazolo[1,5-a]pyrimidines for antiviral treatment
01/05/2012CA2803996A1 Piperidine derivatives and their use for the treatment of metabolic disorders
01/05/2012CA2803842A1 Novel nicotinamide derivative or salt thereof
01/05/2012CA2803752A1 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides
01/05/2012CA2803577A1 2-pyridyl substituted imidazoles as therapeutic alk5 and/or alk4 inhibitors
01/05/2012CA2803358A1 Heterocyclic compounds and their use as inhibitors of pi3k activity
01/05/2012CA2803292A1 Sgc stimulators
01/05/2012CA2803009A1 Heterocyclic compounds and their use as inhibitors of pi3k activity
01/05/2012CA2802492A1 2-quinolinyl-acetic acid derivatives as hiv antiviral compounds
01/04/2012EP2402320A1 Anorectic agents
01/04/2012EP2402319A1 DGAT Inhibitors
01/04/2012EP2402318A1 DGAT inhibitors